XM, Amerika Birleşik Devletleri'nde ikamet edenlere hizmet sunmamaktadır.

XM, Amerika Birleşik Devletleri'nde ikamet edenlere hizmet sunmamaktadır.
L
L

Lanxess

Haberler

Reuters - 3 gün önce

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Eni, Mediobanca, DSV, Stellantis Oct 3 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 2000 GMT on Thursday: ** Italy's Eni ENI.MI will decide about additional stake sales in its renewable and biofuel units, its CEO said on Thursday, keeping in mind that it wants to list them on the stock market and retain the majority of their capital.
C
E
L
M
R
U
Reuters - 3 gün önce

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Oct 3 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 0930 GMT on Thursday: ** German speciality chemicals maker Lanxess LXSG.DE said it has signed a contract to sell its Urethane Systems polymers business to UBE Corporation for about 460 million euros ($507.98 million). nTUC7XXL38 ** Greece's bank bailout fund HFSF has set the final price in a National Bank NBGr.AT equity offering at 7.55 euros ($8.33) per share, tw
L
Reuters - 3 gün önce

Japan's UBE Corp: To Acquire Germany's LANXESS Urethane Systems Business For About 460 Million Euros

BRIEF-Japan's UBE Corp: To Acquire Germany's LANXESS Urethane Systems Business For About 460 Million Euros Oct 3 (Reuters) - UBE Corp 4208.T : UBE CORP - NOTICE REGARDING ACQUISITION OF LANXESS URETHANE SYSTEMS BUSINESS UBE CORP - ACQUISITION PRICE IS ABOUT 460 MILLION EUROS UBE CORP - ACQUISITION EXPECTED TO COMPLETE IN FIRST HALF OF 2025, IMPACT
L
Reuters - 3 gün önce

Lanxess to sell polymers business to UBE Corporation

Lanxess to sell polymers business to UBE Corporation Oct 3 (Reuters) - German speciality chemicals maker Lanxess LXSG.DE said on Thursday it has signed a contract to sell its Urethane Systems polymers business to UBE Corporation. The enterprise value of Lanxess's last remaining polymers business amounts to 460 million euros ($507 million), the company said.
L
Reuters - 1 hafta önce

Lanxess Signs New Sustainable Credit Line For EUR 800 Mln

BRIEF-Lanxess Signs New Sustainable Credit Line For EUR 800 Mln Sept 26 (Reuters) - LANXESS AG LXSG.DE : SIGNS NEW SUSTAINABLE CREDIT LINE FOR EUR 800 MILLION BASIC TERM OF NEW CREDIT LINE IS FIVE YEARS, WITH TWO ONE-YEAR EXTENSION OPTIONS LANXESS HAS AGREED A NEW SYNDICATED CREDIT FACILITY WITH 11 BANKS IT SERVES TO SECURE COMPANY'S LONG-TERM LIQU
L
Reuters - 4 hafta önce

German chemicals sector recovery loses momentum in Q2, says industry group

German chemicals sector recovery loses momentum in Q2, says industry group Sept 10 (Reuters) - A slight recovery in the German chemicals sector lost momentum in the second quarter, a report by the VCI industry body said on Tuesday, as both domestic and foreign orders slowed in the April-June period, especially in the pharmaceutical branch. "The global economy has not picked up speed as hoped," VCI's Managing Director Wolfgang Grosse Entrup said in a press release, adding that Germany's structura
B
L
Reuters - 4 hafta önce

MS says 2025 turning point for EU chemicals, names Akzo as top pick

BUZZ-MS says 2025 turning point for EU chemicals, names Akzo as top pick ** Current demand growth in European chemicals lacks near term catalysts, but is set to improve from 2025, supported by interest rates' cuts and lower gas prices, says Morgan Stanley ** MS analysts anticipate 2.7% supply growth on average over the next four years (vs 4.6% over
A
B
L
W
A
A
Reuters - 4 hafta önce

European shares slip on growth jitters; French stocks lead decline

UPDATE 2-European shares slip on growth jitters; French stocks lead decline Michel Barnier named French prime minister Part of Airbus A350 fleet faces inspection, regulator says China growth concerns weigh on luxury stocks Vistry rises on buyback, higher HY profit STOXX 600 down 0.5% Updated at 1620 GMT By Shubham Batra and Lisa Pauline Mattackal Sept 5 (Reuters) - European stocks fell on Thursday as mixed economic data spurred worries about global growth and offset gains in interest rate-sensit
A
H
L
L
A
A
E
F
G
Reuters - 4 hafta önce

Air Liquide, Novo Nordisk, Syensqo

EUROPE RESEARCH ROUNDUP- Air Liquide, Novo Nordisk, Syensqo Sept 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air Liquide, Novo Nordisk and Syensqo, on Thursday. HIGHLIGHTS * Air Liquide AIRP.PA : Morgan Stanley cuts to underweight from equal-weight * Lanxess AG LXSG.DE : Morgan Stanley raises to overweight from underweight * Novo Nordisk NOVOb.CO : JP Morgan raises target price to DKK 1050 from DKK 950 * Swiss Life Holding AG
A
A
A
A
B
B
C
E
K
L
N
W
A
A
A
S
S
Reuters - 1 ay önce

German chemical firms moving more research abroad, industry body warns

German chemical firms moving more research abroad, industry body warns FRANKFURT, Aug 29 (Reuters) - German chemical companies are increasingly moving their research abroad due to lower costs, less bureaucracy and better public funding programs elsewhere, the industry body VCI warned on Thursday. VCI, which represents almost two thousand companies in the country's third-largest sector, said it expects research spending to slowdown to 2% this year from 4% in 2023. "High inland costs, poor earning
B
L
Reuters - 2 ay önce

Danske Bank, Lotus Bakeries NV, Vesuvius

EUROPE RESEARCH ROUNDUP-Danske Bank, Lotus Bakeries NV, Vesuvius Aug 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Danske Bank, Lotus Bakeries NV and Vesuvius, on Tuesday. HIGHLIGHTS * Abrdn Plc ABDN.L : Morgan Stanley raises target price to 160p from 149p * Danske Bank DANSKE.CO : Morgan Stanley initiates coverage with overweight rating * Lotus Bakeries NV LOTB.BR : Berenberg raises target price to EUR 10,300 from EUR 9,000 *
A
A
A
B
C
D
E
F
H
H
K
L
M
M
N
O
S
S
S
S
S
H
A
S
U
Reuters - 2 ay önce

AstraZeneca, Beazley, Puma

EUROPE RESEARCH ROUNDUP-AstraZeneca, Beazley, Puma Aug 12 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AstraZeneca, Beazley and Puma on Monday. HIGHLIGHTS * AstraZeneca AZN.L : TD Cowen raises target price to 14,860p from 13,945p * Beazley BEZG.L : Jefferies raises target price to 1,020p from 975p * Puma SE PUMG.DE : Baader Helvea raises to buy from add * Quilter Plc QLT.L : Berenberg raises target price to 135p from 105p * WPP
A
B
B
B
D
D
E
H
J
J
L
L
M
M
O
P
S
S
U
V
W
A
A
B
B
R
Reuters - 2 ay önce

European shares jump, weather turbulence to eke out weekly gain

UPDATE 2-European shares jump, weather turbulence to eke out weekly gain For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window LEG Immobilien up on posting smaller Q2 loss Lanxess reassures with positive Q2 free cash flow, shares up UK's Hargreaves Lansdown agrees $6.9 bln takeover by consortium STOXX 600 up Updated at 1600 GMT By Pranav Kashyap and Ankika Biswas Aug 9 (Reuters) - Europe's main index r ose on Friday, with a continued boost fro
B
H
L
L
E
F
I
S
U
G
Reuters - 2 ay önce

Positive Q2 FCF boosts Lanxess shares

BUZZ-Positive Q2 FCF boosts Lanxess shares ** Shares in Lanxess LXSG.DE rise around 4% as the speciality chemicals maker reported a positive quarterly free cash flow (FCF) along with its final Q2 results ** "2Q FCF probably not as bad as was feared," J.P. Morgan says ** Jefferies also highlights the positive FCF figure, adds all divisions beat consensus on adj.
L
Reuters - 2 ay önce

Lanxess reassures with positive Q2 free cash flow

UPDATE 3-Lanxess reassures with positive Q2 free cash flow Posts Q2 free cash flow of 83 million euros Q2 sales decline 5.6% Shares up as much as 6% Recasts to focus on free cash flow, updates shares in paragraph 1 and 6, adds analyst comments throughout, CEO comment in 8 By Linda Pasquini Aug 9 (Reuters) - Germany's Lanxess LXSG.DE generated more cash than expected in the second quarter, boosting its shares on Friday even as the speciality chemicals maker missed sales forecasts.
L
Reuters - 2 ay önce

Lanxess Forecast For Full Year 2024 Unchanged

BRIEF-Lanxess Forecast For Full Year 2024 Unchanged Aug 9 (Reuters) - LANXESS AG LXSG.DE : FORECAST FOR FULL YEAR 2024 UNCHANGED FOR Q4, GROUP THEN ANTICIPATES A MORE MUTED PERFORMANCE AS A RESULT OF NORMAL SEASONAL DEVELOPMENT. EBITDA MARGIN PRE EXCEPTIONALS FOR Q2 AMOUNTED TO 10.8 PERCENT COMPARED TO 6.0 PERCENT IN SAME PERIOD OF PREVIOUS YEAR Q2
L
Reuters - 2 ay önce

Lanxess sales drop 5.6% in Q2

Lanxess sales drop 5.6% in Q2 Aug 9 (Reuters) - Speciality chemicals maker Lanxess LXSG.DE on Friday reported a 5.6 % drop in its second-quarter sales, below market expectations, citing lower selling prices as it passed on reduced raw material and energy costs. The Cologne-based company posted revenue of 1.68 billion euros ($1.83 billion) for the second quarter, missing analysts' forecast of 1.72 billion in a poll by Vara Research.
L
Reuters - 2 ay önce

Standard Lithium names David Park as CEO

Standard Lithium names David Park as CEO Aug 1 (Reuters) - Canadian miner Standard Lithium SLI.V on Thursday named David Park as its new chief executive officer, effective Sept. 1, succeeding longtime CEO Robert Mintak. The incoming CEO has served as a strategic advisor for Standard Lithium over the past year and helped the lithium miner secure an investment from Equinor ASA EQNR.OL in projects located in Southwest Arkansas and East Texas.
E
L
Reuters - 3 ay önce

Lanxess soars as Q2 adj. EBITDA exceeds expectations

BUZZ-Lanxess soars as Q2 adj. EBITDA exceeds expectations ** Shares in Lanxess LXSG.DE rise 17.8% after the German speciality chemicals maker posted Q2 adjusted EBITDA above expectations ** Q2 adjusted EBITDA of EUR 181 mln ($198.01 mln), boosted by inventory reduction and cost-saving measures, beats company-compiled consensus by 32% ** This comes
L
Reuters - 3 ay önce

Lanxess Q2 core profit beats expectations, shares jump

UPDATE 2-Lanxess Q2 core profit beats expectations, shares jump Q2 EBITDA pre-exceptionals at 181 mln euros Sees Q3 EBITDA pre-exceptionals at about Q2 level Shares soar as much as 22% Adds CEO quote in paragraph 4, context in paragraph 7 and updates share move in paragraph 8 By Ozan Ergenay and Linda Pasquini July 17 (Reuters) - Lanxess LXSG.DE reported a better-than-expected preliminary core profit for the second quarter, and gave an upbeat guidance for the third quarter, sending its shares so
L

Şartlar

Popüler varlıklar

Bildirim: XM Group şirketlerinin her biri yalnızca gerçekleştirme hizmeti ve online yatırım platformumuza erişim sağlar. Herhangi bir kişinin web sitesinde bulunan veya web sitesi üzerinden sağlanan içeriği görüntülemesine ve/veya kullanmasına izin vermek, bu hizmeti değiştirmek veya genişletmek amaçlı değildir ve bu hizmeti ne değiştirir ne de genişletir. Bu tür erişim ve kullanım her zaman şunlara tabidir: (i) Şartlar ve Koşullar; (ii) Risk Uyarıları ve (iii) Tam Bildirim. Bu nedenle bu tür içerikler yalnızca genel bilgi amacıyla sağlanır. Özellikle, online yatırım platformumuzun içeriklerinin finans piyasalarında herhangi bir işleme girmek için bir teşvik veya bir teklif olmadığını lütfen dikkate alın. Herhangi bir finans piyasasında yatırım yapmak sermayeniz için önemli düzeyde risk taşır.

Online yatırım platformumuzda yayınlanan tüm materyaller yalnızca eğitim/bilgilendirme amaçlıdır ve finansal tavsiye, yatırım vergisi veya yatırım tavsiyesi ve önerileri ya da yatırım fiyatlarımızın kaydı veya herhangi bir finansal enstrümanda işlem yapılması için bir teklif veya teşvik ya da talep edilmemiş finansal promosyonları içermez ve içerdiği şeklinde bir değerlendirme yapılmamalıdır.

Görüşler, haberler, araştırma, analizler, fiyatlar, diğer bilgiler veya bu web sitesinde bulunan üçüncü taraf sitelere verilen bağlantılar gibi her türlü üçüncü taraf içeriğin yanı sıra XM tarafından hazırlanan içerik de “olduğu gibi” esasına göre, genel piyasa yorumu olarak sağlanır ve bir yatırım tavsiyesi oluşturmaz. Herhangi bir içeriğin yatırım araştırması olarak yorumlanmasıyla ilgili olarak, içeriğin bağımsız yatırım araştırmasını desteklemek üzere tasarlanmış yasal gerekliliklere uygun hazırlanmadığını ve bu amacın güdülmediğini, aynı şekilde ilgili yasalar ve mevzuatlar kapsamında pazarlama iletişimi olarak değerlendirileceğini dikkate almalı ve kabul etmelisiniz. Buradan erişebileceğiniz Bağımsız Olmayan Yatırım Araştırması Bildirimimizi ve yukarıdaki bilgilerle ilgili Risk Uyarımızı okuduğunuzdan ve anladığınızdan emin olun.

Risk uyarısı: Sermayeniz risk altında. Kaldıraçlı ürünler herkese uygun olmayabilir. Lütfen Risk Bildirimi'mizi dikkate alın.